ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Clinical trials for ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested in Tough-to-Treat blood cancers
Disease control OngoingThis study is testing whether combining two drugs, CPX-351 and glasdegib, is safe and effective for adults with specific types of acute myeloid leukemia (AML) who have not yet received treatment. The main goal is to see how many patients are still in remission and event-free six …
Matched conditions: ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug added to standard chemo
Disease control OngoingThis study is testing a new drug called pevonedistat, given alongside standard chemotherapy drugs, for adults newly diagnosed with high-risk acute myeloid leukemia (AML). The main goals are to find the safest and most effective dose of the new combination and to see if it helps m…
Matched conditions: ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New hope for tough leukemia in younger patients
Disease control OngoingThis study is testing how well a chemotherapy drug called CPX-351 works for adults under 60 with secondary acute myeloid leukemia, a type of blood cancer that develops from other blood disorders or previous cancer treatments. The goal is to see if this drug can help patients achi…
Matched conditions: ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC